Effects of GSM-like radiofrequency on distortion product otoacoustic emissions in pregnant adult rabbits
Gürer G Budak MD, PhD1
Nuray Bayar Muluk MD4
Göknur Güler Öztürk PhD2
Bilgehan Budak PhD6
Alpaslan Apan MD5
Nesrin Seyhan PhD2
Cihat Şanli MD3
1 Nanomedicine Research Laboratory, 2 Department of Biophysics, 3 Department of Pediatric Cardiology, Gazi University Faculty of Medicine, Ankara, Turkey
4 ENT Department, 5 Department of Anesthesiology and Reanimation, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkey
6 ENT Department, Hacettepe University, Ankara, Turkey
Manuscript submitted 3rd December, 2008
Manuscript accepted 14th January, 2009
Clin Invest Med 2009; 32 (2): E112-E116.
Abstract
Objectives: To determine the effects of 1800 MHz GSM-like
Radiofrequency (RFR) on the cochlear functions of pregnant adult rabbits by
Distortion Product Otoacoustic Emissions (DPOAEs).
Methods: Eighteen 13-month-old pregnant and eighteen 13-month-old non-pregnant New Zealand White rabbits were studied. They were randomly divided into four groups. Nine pregnant rabbits (Group 2) and nine non-pregnant rabbits (Group 4) were exposed to 1800 MHz GSM-like RFR 15 min daily for 7 days. Nine pregnant (Group 1) and nine non-pregnant rabbits (Group 3) were not exposed to GSM like RFR. Cochlear functions were assessed by DPOAEs at 1.0-8.0 kHz.
Results: In all pregnant groups except 2.0 kHz, DPOAE amplitudes were not different in Group 2 and Group1. In Group 4, DPOAE amplitudes at 1.0-4.0 kHz (-1.68 dB SPL at 1.0 kHz, 3.05 dB SPL at 1.5 kHz, 2.96 dB SPL at 2.0 kHz, 1.30 dB SPL at 3.0 kHz and 12.22 dB SPL at 4.0 kHz) were lower than Group 3 (8.67 dB SPL at 1.0 kHz, 17.67 dB SPL at 1.5 kHz, 26.10 dB SPL at 2.0 kHz, 18.10 dB SPL at 3.0 kHz and 35.13 dB SPL at 4.0 kHz) (P<0.0125). In the pregnant group, harmful effects of GSM-like RFR were less than in the non-pregnant group.
Conclusion: GSM-like RFR caused decreases in DPOAE amplitudes mainly in non-pregnant adult rabbits. Prolonged exposure may affect the DPOAE amplitude. Recommendations are given to prevent the potential hazardous effects of RF in humans.
Mobile phones have become very commonly used throughout the world.1 The effects of nonthermal radiofrequency radiation (RFR) of the global system of mobile communication (GSM) cellular phones have been studied mostly at the molecular level in the context of cellular stress and proliferation, as well as neurotransmitter production and localization.
GSM-like RFR interferes with gene expression during early gestation.2 After exposure to 900 and 1800 MHz EMFs, produced by mobile phones, no immediate after-effects on Transient Evoked Otoacoustic Emissions (TEOAEs) or measurable hearing deterioration were seen in 30 subjects.3 Similarly, when the effects of mobile phone-like 900 MHz EMFs on cochlear function in rats were investigated, no difference in distortion product otoacoustic emissions (DPOAE) records were reported.4 Parazzini M , et al 1 reported that 10 min EMF exposure at the maximum power (2 W at 900 MHz or 1 W at 1800 MHz) did not induce any change in either DPOAE generation mechanism.
OAEs are by products of cochlear function and OAE characteristics over a range of stimuli provide information about cochlear status. DPOAEs are evoked upon stimulation by two frequency tones, F1 and F2, and are generated at the frequencies that combine these primary tones due to their nonlinear interaction. Although DPOAE analysis is complex and interpretation is difficult, it has been used for advanced clinical investigations on adults.5 DPOAEs have been used previously as indicators of cochlear status following exposure to mobile phone-like EMFs.1,4
The potential hazardous effects of 1800 MHz GSM-like Radiofrequency (RFR) on cochlear function in pregnancy is an important question that needs to be answered. We could not find any previous studies on the subject. Thus, to investigate and evaluate the issue, we planned a study in rabbits. Pregnant and non-pregnant adult rabbits were exposed to 1800 MHz GSM-like RFR and cochlear function was investigated by DPOAEs comparing pregnant and nonpregnant controls.
Materials and Methods
The experimental protocol was reviewed and approved by the Laboratory Animal Care Committee of Gazi University. All animal procedures were performed in accordance with the approved protocol and in compliance with the principles of the Declaration of Helsinki.6
Animal Subjects
Eighteen 13-month-old nonpregnant and eighteen 13-month-old pregnant New Zealand White rabbits were obtained from the Laboratory Animals Breeding and Experimental Researches Center of Gazi University. They were housed under the same conditions in a temperature and humidity controlled room (20±1°C, 50 ± 10% relative humidity) and 14-16 h light/dark cycle conditions. Except during exposure periods, tap water and standard pelletized food were provided ad libitum.
For breeding, virgin female rabbits were placed individually with male rabbits. After mating, their pregnancies were verified by abdominal palpation ten days later. Pregnant and nonpregnant rabbits were adapted to the laboratory conditions for five days before the experiment. During the five days, quality controls were conducted to verify that the rabbits were healthy.
Pregnant rabbits, 15th – 22nd day of gestation, and nonpregnant rabbits were exposed to RFR after the adaptation period. Only one animal was placed in each cage during each RF exposure period.
Experimental Design
Nonpregnant and pregnant adult New Zealand White rabbits were randomly divided into four groups:
1. Group 1 [Pregnant- Control, RF(-)]: 9 pregnant rabbits GSM-RF not applied.
2. Group 2 [Pregnant-RFR Exposed RF(+)]: 9 pregnant rabbits, GSM-RF of 1800 MHz applied for 15min/day for 7 days.
3. Group 3 [Nonpregnant- Control, RF(-)]: 9 non-pregnant rabbits GSM-RF not applied
4. Group 4 [Nonpregnant- RFR Exposed RF(+)]: 9 non-pregnant adult rabbits, GSM-RF of 1800 MHz applied for 15min/day for 7 days.
Exposure Level and Quality Control
GSM-like 1800 MHz frequency signals were formed using a signal generator (Agilent Technologies 8648C, 9 kHz- 3.2 GHz) with the integrated pulse modulation unit and horn antenna (Schwarzbeck, Doppelsteg Breitband Horn antenna BBHA 9120 L3F, 0.5 - 2.8 GHz) in a shielded room. The generated power was controlled by a spectrum analyzer (Agilent Technologies N9320A, 9 kHz - 3 GHz) integrated to the signal generator. The signal amplitude was modulated by rectangular pulses with a repetition frequency of 217 Hz and a duty cycle of 1:8 (pulse width 0.576 ms), corresponding to the dominant modulation component of GSM.
An RFR Generator provided 20 dB (0.1 W) power during exposure. The signal was controlled by a spectrum analyzer connected to the signal generator. A NARDA EMR 300 and type 26.1 probe were used for measurement of the output radiation. The design of the exposure system and quality controls were performed in Bioelectromagnetics Laboratory of Biophysics Discipline of Gazi University Medical School.
DPOAE Recordings
Prior to the experimental DPOAE measurements, the ears of the rabbits were examined by otoscope and animals with external auditory canal or eardrum pathology were excluded. Animals were anesthetized both during examinations and experiments with 40 mg/kg ketamine hydrochloride (Ketalar, Parke-Davis, USA) and 5 mg/kg xylazine hydrochloride (Rompun, Bayer, Germany) im. Eye-blink reflexes and respiratory rhythm were followed during the experiments.
DPOAE was generated in 72 ears by ILO 288 USB II (Otodynamics Ltd Clinical OAE System, England) cochlear emission analyzer. The acoustic stimulus consisted of two simultaneous continuous pure tones at different frequencies; F1 and F2 (F2/F1: 1.22). Intensities, L1 and L2, are expressed as 80 dB sound pressure level (SPL).
Recordings were performed in an isolated quiet environment and the rabbits were sedated and motionless with regular spontaneous breathing. Plastic tubing adapters that gave the optimal fit to the external auditory canal were attached to the emission probe and a closed cavity was formed by placing the probe into the external auditory canal. DPOAE recordings and assessments were performed at the laboratories of Physiology Discipline of Gazi University Medical School.
Statistical Analysis
A statistical packet for SPSS (Version 9.0) was used for statistical evaluation. At each DPOAE frequency (1.0-8.0 kHz), the difference between DPOAE amplitudes of Groups 1-4 were analyzed by Kruskal Wallis Variance Analysis. When statistically significant results were present, a Wilcoxon Matched-Pairs Signed-Ranks Test with Bonferroni correction was used. P < 0.05 was considered statistically significant.
Results
In Group 1, DPOAE amplitudes were 5.06 dB SPL at 1.0 kHz, 18.71 dB SPL at 1.5 kHz, 22.80 dB SPL at 2.0 kHz, 19.57 dB SPL at 3.0 kHz, 32.21 dB SPL at 4.0 kHz, 26.14 dB SPL at 6.0 kHz and 17.18 dB SPL at 8.0 kHz. In Group 2, DPOAE amplitudes were -2.19 dB SPL at 1.0 kHz, 5.72 dB SPL at 1.5 kHz, 6.93 dB SPL at 2.0 kHz, 5.96 dB SPL at 3.0 kHz, 16.58 dB SPL at 4.0 kHz, 14.24 dB SPL at 6.0 kHz and 6.27 dB SPL at 8.0 kHz. In Group 3 DPOAE amplitudes were 8.67 dB SPL at 1.0 kHz, 17.67 dB SPL at 1.5 kHz, 26.10 dB SPL at 2.0 kHz, 18.10 dB SPL at 3.0 kHz, 35.13 dB SPL at 4.0 kHz, 26.07 dB SPL at 6.0 kHz and 18.52 dB SPL at 8.0 kHz.In Group 4, DPOAE amplitudes were -1.68 dB SPL at 1.0 kHz, 3.05 dB SPL at 1.5 kHz, 2.96 dB SPL at 2.0 kHz, 1.30 dB SPL at 3.0 kHz, 12.22 dB SPL at 4.0 kHz, 4.88 dB SPL at 6.0 kHz and -5.78 dB SPL at 8.0 kHz. Significant differences were present at all frequencies.
Discussion
In the GSM-like RFR exposed non-pregnant group DPOAE amplitudes at 1.0-4.0 kHz were lower, and at 6.0-8.0 kHz were no different from the non-GSM-like RFR exposed non-pregnant group. In all pregnant groups except 2.0 kHz, there was no difference for DPOAE amplitudes between RFR exposed and non-RFR exposed groups.
There is limited previous information
on the potential adverse effects of EMFs and mobile phones on hearing1: adverse effects are
mainly result of prolonged exposure.7 Parazzini, et al. 8
investigated the internal electric and magnetic field distribution of the inner
hearing system exposed to 900 and 1800 MHz. They found: 1) higher internal
field strength in the vestibular region than in the auditory region, especially
for the inner ear closer to the external source; 2) higher internal fields
strength in the basal and apical than in the middle region of the cochlea. No
previous studies have explored the effects of EMF non-ionising radiations
either on the DPOAE phase gradient or on the amplitude of each DPOAE emission
component.1
In the present study, decrease in the DPOAE amplitudes after exposure to GSM-like RFR in the non-pregnant group may be related to a decrease in cochlear activity and decreased activity in the outer hair cell electromotility due to prolonged exposure.8 In pregnancy, although increased endolymph production due to estrogen levels and higher corticosteroid levels9-11 may protect the inner ear from the hazardous effects of RFR.
We recommend the following measures to prevent the potential hazardous effects of RF in humans: 1. Avoid prolonged use of mobile phones. 2. Avoid near exposure to GSM-like RF and use ear-phones for talking with mobile phones. 3. Encourage non-continuous or temporary RF exposure.
We conclude that long-term exposure to GSM-like RFR may cause decrease of DPOAE amplitude. In pregnancy, increased inner ear volume may help to reduce the damage. This study shows only the early effects of GSM-like RFR. Future studies should investigate the late effects of GSM-like RFR.
References
1. Parazzini M, Bell S, Thuroczy G, et al. Influence on the mechanisms of generation of distortion product otoacoustic emissions of mobile phone exposure. Hear Res 2005;208:68-78.
2. Pyrpasopoulou A, Kotoula V, Cheva A, et al. Bone morphogenetic protein expression in newborn rat kidneys after prenatal exposure to radiofrequency radiation. Bioelectromagnetics. 2004;25:216-27.
3. Uloziene I, Uloza V, Gradauskiene E, Saferis V. Assessment of potential effects of electromagnetic fields of mobile phones on hearing. BMC Public Health 2005;5:39.
4. Galloni P, Lovisolo GA, Mancini S, et al. Effects of 900 MHz electromagnetic fields exposure on cochlear cells' functionality in rats: evaluation of distortion product otoacoustic emissions. Bioelectromagnetics 2005;26:536-47.
5. Kemp DT. Otoacoustic emissions, their origin in cochlear function, and use. Br Med Bull 2002;63:223-41.
6. 52nd WMA General Assembly. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000;284:3043-9.
7. Tice RR, Hook GG, Donner M, McRee DI, Guy AW. Genotoxicity of radiofrequency signals. I. Investigation of DNA damage and micronuclei induction in cultured human blood cells. Bioelectromagnetics 2002;23:113–26.
8. Parazzini M, Tognola G, Franzoni C, Grandori F, Ravazzani P. Modeling of the internal fields distribution in human inner hearing system exposed to 900 and 1800 MHz. IEEE Trans Biomed Eng. 2007;54:39-48.
9. Sasaki A, Liotta AS, Luckey MM, Margioris AN, Suda T, Krieger DT. Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy. J Clin Endocrinol Metab. 1984;59:812-4.
10. Rees LH, Burke CW, Chard T, Evans SW, Letchworth AT. Possible placental origin of ACTH in normal human pregnancy. Nature. 1975; 254:620-2.
11. Creasy RK, Resnik R. Maternal-Fetal Medicine, 4th Edition, Philadelphia: W.B. Saunders Company 1999; pp 1015-37.
Correspondence to:
Dr. Nuray Bayar Muluk
Birlik Mahallesi, Zirvekent 2. Etap Sitesi, C-3 blok, No: 62/43
06610 Çankaya / Ankara, Turkey
E-mail: nbayarmuluk@yahoo.com or nurayb@hotmail.com
|
TABLE 1: DPOAE amplitudes for the frequencies 1.0-8.0 kHz of the Groups 1-4 |
||||||||
|
Groups |
DPOAE Results (dB) |
|||||||
|
1.0 kHz |
1.5 kHz |
2.0 kHz |
3.0 kHz |
4.0 kHz |
6.0 kHz |
8.0 kHz |
||
|
Pregnant Rabbits |
Group 1 Pregnant, RF (-) |
5.06± 7.71 |
18.71± 13.59 |
22.80± 21.75 |
19.57± 22.59 |
32.21± 23.86 |
26.14± 24.99 |
17.78± 25.09 |
|
Group 2 Pregnant, RF (+) |
-2.19± 15.17 |
5.72± 20.94 |
6.93± 22.89 |
5.96± 17.86 |
16.58± 22.57 |
14.24± 27.08 |
6.27± 26.32 |
|
|
Non-pregnant Rabbits |
Group 3 Non-pregnant, RF(-) |
8.67± 9.29 |
17.67± 19.39 |
26.10± 19.08 |
18.10± 19.06 |
35.13± 22.03 |
26.07± 24.27 |
18.52± 29.63 |
|
Group 4 Non-pregnant, RF(+) |
-1.68± 6.48 |
3.05± 12.80 |
2.96± 18.99 |
1.30± 19.69 |
12.22± 23.50 |
4.88± 28.52 |
-5.78± 27.04 |
|
|
P* |
0.008 |
0.025 |
0.002 |
0.028 |
0.006 |
0.030 |
0.016 |
|
|
* Kruskal Wallis Variance Analysis. Values - mean±SD |
||||||||
© 2007-2012 Canadian Society for Clinical Investigation.
C.I.M. provides open access to all of its content 6 months after the date of publication